Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems
about
Progress of artificial pancreas devices towards clinical use: the first outpatient studiesEffect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System.Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes SubjectsAn artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes.Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia.Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use.Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes.Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
P2860
Q26825236-490533DA-3B8A-4E18-B9EA-C4075CDB603AQ36186004-D3D1D1BE-E3FB-45F2-8A32-CCB7F7CC6AF1Q37275444-8D957657-A364-4D5A-9149-82C06C1EABCBQ38498029-46D55ABA-5425-4B4E-9616-DF91EC122928Q38821167-DA985EC4-A9FC-428D-844B-8A7514E0791CQ39413453-6AECA50E-05A0-48DC-BC6F-5090AF5B1E84Q42008289-FBA85E00-BB77-4B96-A9D4-8DAE5034F3A7Q47558223-B4D4D3FA-74F4-466B-95E3-6ACE1E8265F9Q47897234-E0D60E1C-551A-40A5-A4FB-7560BBD34658Q51654262-3E8C04F3-6F5F-47E8-9474-BAC1FF55BBCFQ55514033-43760847-A683-4FF1-B20D-ABC41DFE94CCQ58701212-D15D5775-DCB9-4964-BEC8-F9035E15AB79
P2860
Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development of a highly stable ...... very via infusion pump systems
@ast
Development of a highly stable ...... very via infusion pump systems
@en
type
label
Development of a highly stable ...... very via infusion pump systems
@ast
Development of a highly stable ...... very via infusion pump systems
@en
prefLabel
Development of a highly stable ...... very via infusion pump systems
@ast
Development of a highly stable ...... very via infusion pump systems
@en
P2093
P2860
P356
P1476
Development of a highly stable ...... very via infusion pump systems
@en
P2093
Brett Newswanger
Jessica Castle
Neelima Phadnis
Robert W Campbell
Steve Ammons
Steven J Prestrelski
W Kenneth Ward
P2860
P356
10.1177/1932296814565131
P577
2015-01-01T00:00:00Z